Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Statistics

Total Valuation

ABUS has a market cap or net worth of $603.16 million. The enterprise value is $486.66 million.

Market Cap	603.16M
Enterprise Value	486.66M

Important Dates

The next estimated earnings date is Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

ABUS has 191.48 million shares outstanding. The number of shares has increased by 11.84% in one year.

Current Share Class	191.48M
Shares Outstanding	191.48M
Shares Change (YoY)	+11.84%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	47.44%
Float	136.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	94.75
Forward PS	94.61
PB Ratio	6.15
P/TBV Ratio	6.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	78.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.15, with a Debt / Equity ratio of 0.06.

Current Ratio	8.15
Quick Ratio	8.02
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-537.91

Financial Efficiency

Return on equity (ROE) is -68.76% and return on invested capital (ROIC) is -42.21%.

Return on Equity (ROE)	-68.76%
Return on Assets (ROA)	-33.36%
Return on Invested Capital (ROIC)	-42.21%
Return on Capital Employed (ROCE)	-63.48%
Revenue Per Employee	$140,250
Profits Per Employee	-$1.59M
Employee Count	44
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.71% in the last 52 weeks. The beta is 1.45, so ABUS's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	+7.71%
50-Day Moving Average	3.31
200-Day Moving Average	3.60
Relative Strength Index (RSI)	46.32
Average Volume (20 Days)	1,326,094

Short Selling Information

The latest short interest is 9.85 million, so 5.14% of the outstanding shares have been sold short.

Short Interest	9.85M
Short Previous Month	9.57M
Short % of Shares Out	5.14%
Short % of Float	7.22%
Short Ratio (days to cover)	9.76

Income Statement

In the last 12 months, ABUS had revenue of $6.17 million and -$69.92 million in losses. Loss per share was -$0.38.

Revenue	6.17M
Gross Profit	-47.87M
Operating Income	-73.69M
Pretax Income	-77.09M
Net Income	-69.92M
EBITDA	-72.31M
EBIT	-73.69M
Loss Per Share	-$0.38

Balance Sheet

The company has $122.62 million in cash and $6.12 million in debt, giving a net cash position of $116.51 million or $0.61 per share.

Cash & Cash Equivalents	122.62M
Total Debt	6.12M
Net Cash	116.51M
Net Cash Per Share	$0.61
Equity (Book Value)	97.37M
Book Value Per Share	0.51
Working Capital	111.70M

Cash Flow

In the last 12 months, operating cash flow was -$64.85 million and capital expenditures -$182,000, giving a free cash flow of -$65.03 million.

Operating Cash Flow	-64.85M
Capital Expenditures	-182,000
Free Cash Flow	-65.03M
FCF Per Share	-$0.34

Margins

Gross Margin	n/a
Operating Margin	-1,194.20%
Pretax Margin	-1,133.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABUS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.84%
Shareholder Yield	n/a
Earnings Yield	-11.59%
FCF Yield	-10.78%

Analyst Forecast

The average price target for ABUS is $5.50, which is 74.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.50
Price Target Difference	74.88%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	95.66%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABUS has an Altman Z-Score of -4.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.49
Piotroski F-Score	3